VOLITIONRX LIMITED

13215 Bee Cave Parkway

Suite 125, Galleria Oaks B

Austin, Texas 78738

 

February 13, 2020

 

 

SUBMITTED VIA EDGAR

 

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attention:  William Mastrianna

 

Re:VolitionRx Limited Acceleration Request 

Registration Statement on Form S-3

File No. 333-236335

 

Requested Date:February 14, 2020 

Requested Time:5:00 P.M. Eastern Time 

 

Dear Mr. Mastrianna:

 

Pursuant to Rule 461 of the Securities Act of 1933, as amended (the “Securities Act”), VolitionRx Limited, a Delaware corporation (the “Company”), hereby respectfully requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to declare the above-captioned Registration Statement on Form S-3 effective at the “Requested Date” and “Requested Time” set forth above, or as soon thereafter as practicable.

 

Should the Commission have any questions regarding this acceleration request, please do not hesitate to contact Marc G. Alcser, an attorney with the Company’s outside legal counsel, Stradling Yocca Carlson & Rauth, P.C., via telephone at (949) 725-4136 or via email at malcser@sycr.com.

 

Sincerely,

 

VOLITIONRX LIMITED

 

/s/ Cameron Reynolds

 

Cameron Reynolds

President and Chief Executive Officer

 

cc:

 

Stradling Yocca Carlson & Rauth, P.C.

Marc G. Alcser, Esq.